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Abstract
AIM
To compare the Glasgow-Blatchford score (GBS), 
Rockall score (RS) and Baylor bleeding score (BBS) in 
predicting clinical outcomes and need for interventions 
in patients with bleeding peptic ulcers. 
METHODS
Between January 2008 and December 2013, 1012 
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consecutive patients admitted with peptic ulcer bleeding 
(PUB) were prospectively followed. The pre-endoscopic 
RS, BBS and GBS, as well as the post-endoscopic 
diagnostic scores (RS and BBS) were calculated for 
all patients according to their urgent upper endo-
scopy findings. Area under the receiver-operating 
characteristics (AUROC) curves were calculated for 
the prediction of lethal outcome, rebleeding, needs for 
blood transfusion and/or surgical intervention, and the 
optimal cutoff values were evaluated.
RESULTS
PUB accounted for 41.9% of all upper gastrointestinal 
tract bleeding, 5.2% patients died and 5.4% patients 
underwent surgery. By comparing the AUROC curves 
of the aforementioned pre-endoscopic scores, the RS 
best predicted lethal outcome (AUROC 0.82 vs  0.67 vs  
0.63, respectively), but the GBS best predicted need for 
hospital-based intervention or 30-d mortality (AUROC 
0.84 vs  0.57 vs  0.64), rebleeding (AUROC 0.75 vs  0.61 
vs  0.53), need for blood transfusion (AUROC 0.83 vs  
0.63 vs  0.58) and surgical intervention (0.82 vs  0.63 
vs  0.52) The post-endoscopic RS was also better than 
the post-endoscopic BBS in predicting lethal outcome 
(AUROC 0.82 vs  0.69, respectively).
CONCLUSION
The RS is the best predictor of mortality and the GBS 
is the best predictor of rebleeding, need for blood 
transfusion and/or surgical intervention in patients with 
PUB. There is no one 'perfect score' and we suggest 
that these two tests be used concomitantly.
Key words: Upper gastrointestinal bleeding; Peptic ulcer 
bleeding; Glasgow-Blatchford score; Rockall score; 
Baylor bleeding score
© The Author(s) 2017. Published by Baishideng Publishing 
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Core tip: Endoscopic hemostasis represents the corner-
stone of upper gastrointestinal bleeding treatment, and 
several scores have been developed for the prediction 
of rebleeding. This is a first study on Croatian patients 
to include over 1000 participants with peptic ulcer 
bleeding, and the aim was to compare three scores 
(Glasgow Blatchford score, Rockall score and Baylor 
bleeding score) in the prediction of peptic ulcer bleeding 
treatment outcome, including need for hospital-based 
intervention or 30-d mortality, 30-d rebleeding rate, 
30-d mortality rate, and needs for surgical intervention 
and blood transfusion, and to find optimal cutoff values 
that indicate high-risk patients.
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INTRODUCTION
Upper gastrointestinal bleeding (UGIB) is a com­
mon medical emergency. Incidence rates of UGIB 
demonstrate variations ranging from 48 to 160 cases 
per 100000 population[1]. The most common causes of 
acute UGIB are non­variceal, where 28% to 59% are 
caused by peptic ulcer bleeding (PUB)[1­3]. Endoscopic 
hemostasis represents the cornerstone of UGIB treat­
ment, and several scores have been developed for the 
prediction of clinical intervention (i.e. Rockall score 
(RS), Glasgow­Blatchford score (GBS), Baylor bleeding 
score (BBS), Cedars­Sinai Medical Center predictive 
index, Almela score, AIMS65 score)[4­14]. The recently 
published American College of Gastroenterology 
practice guidelines on the management of patients 
with ulcer bleeding recommend risk assessment in 
all patients in order to stratify them into high or low 
risk categories, since it may assist in initial decisions 
regarding the timing of endoscopy, time of discharge, 
and level of care[15]. 
The GBS is a pre­endoscopic score and contains the 
following parameters: initial hemoglobin levels, urea, 
blood pressure, pulse, known syncope, melena, and 
liver or cardiac failure. Each variable has an appointed 
numeric value and the maximal number of points is 
23 (Table 1). The GBS was designed to predict lower 
risk bleeds, and a GBS value of 1 or lower indicates 
very low risk category[8,9]. The most commonly used 
RS consists of a pre­endoscopic evaluation part, which 
includes age, signs of shock and comorbidities, along 
with an endoscopic part, which evaluates high­risk 
endoscopic characteristics as well (known as the post­
endoscopic RS) (Table 2). Each variable is appointed 
a numeric value and every value > 2 indicates a high­
risk patient[7]. The maximal pre­endoscopic RS value is 
7, and the maximal post­endoscopic value is 11. The 
post­endoscopic RS can be calculated if bleeding is 
diagnosed and evaluated with upper endoscopy[7,16,17]. 
The BBS contains a pre­endoscopic evaluation part, 
which includes age, severity and duration of associated 
diseases, along with a post­endoscopic part, which 
evaluates the position and type of fresh bleeding (Table 
3). The maximal pre­endoscopic BBS is 15, and the 
maximum total (pre­endoscopic and post­endoscopic) 
BBS is 24[18].
The RS was primarily developed to predict 
mortality and the GBS to evaluate need for clinical 
intervention[6­14]. Secondarily, they can be applied to 
asses rebleeding risk. The BBS was primarily developed 
to identify patients at high risk for rebleeding after 
endoscopic hemostasis[6,16]. In previous studies, 
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the GBS has been shown to be better than the pre­
endoscopic and post­endoscopic RS in predicting the 
need for hospital­based intervention in patients with 
UGIB[6,13,19]. On the other hand, the RS appeared to 
be better at predicting mortality after rebleeding, 
contributing to more accurate diagnostics and shorter 
hospital stay[7,13,14]. Recent studies have shown 
that early endoscopy (within 24 h of presentation) 
is performed in only half of patients with UGIB, 
demonstrating the need for reliable and accurate pre­
endoscopic risk assessment[6­15,20­25].
This is the first prospective study in Croatia to 
include over 1000 patients with PUB, and the aim 
was to compare the GBS, pre­endoscopic RS and 
pre­endoscopic BBS, as well as the post­endoscopic 
RS and post­endoscopic BBS, in the prediction of 
PUB treatment outcome, need for hospital­based 
intervention (endoscopic treatment, transfusion, 
surgery intervention) or 30­d mortality, including 30­d 
rebleeding rate, 30­d mortality rate, and needs for 
surgical intervention and blood transfusion, and to find 
optimal cutoff values that indicate high­risk patients.
MATERIALS AND METHODS
This prospective study was conducted in the University 
Hospital Center “Sestre Milosrdnice” that covers 
a population of approximately 300000 in the City 
of Zagreb, Croatia. All patients presenting to the 
Emergency Unit between January 2008 and December 
2013 with hematemesis, melena, hematochezia, or 
blood admixture upon nasogastric insertion were 
considered for study enrolment. If initial work­up 
indicated the need for hospitalization, patients were 
admitted to the Interventional Gastroenterology Unit.
Upper gastrointestinal endoscopy was performed 
in all patients within 24 h of admission. Only patients 
with gastric and/or duodenal ulcers, or an ulcer at 
the site of gastro­enteric anastomosis found during 
emergency endoscopy, without any other possible 
cause of bleeding were included in the study. All 
patients with high­risk ulcer stigmata and patients 
selected depending on clinical judgment received 
high­dose acid suppression therapy (pantoprazole or 
esomeprazole 80 mg as an intravenous bolus, followed 
by 40 mg intravenously 2 times daily or 200 mg daily 
in the form of continuous infusion for at least 48 h 
followed by 40 mg daily by mouth). The institution’
s ethics committee approved the study. Data was 
prospectively entered into a database, with patient 
details stored in a depersonalized manner to protect 
patient confidentiality.
Data collection
The following data were collected for each patient: 
demographic data, history of ulcer or liver disease, 
coexisting and past illnesses, medication use, clinical 
characteristics of the bleeding episode, laboratory 
results, endoscopic diagnosis including stigmata of 
ongoing or recent hemorrhage, endoscopic interven­
tion, medical treatment, rebleeding, surgical therapy, 
duration of hospitalization and cause of death. The 
grading of overall health and co­morbidity was 
performed according to the American Society of 
Anesthesiology (ASA) classification (grade 1, normal 
healthy patients; grade 2, mild systemic illness; grade 
3, severe but incapacitating systemic illness; grade 4, 
life­threatening illness). Stigmata of hemorrhage were 
defined according to the Forrest classification (Forrest 
Ia, spurting bleeding; Forrest Ib, oozing bleeding; 
Forrest Ⅱa, non-bleeding visible vessel; Forrest Ⅱ
b, adherent clot; Forrest Ⅱc, hematin on ulcer base; 
Forrest Ⅲ, clean ulcer base). 
Shock was defined as syncope or signs of shock at 
physical examination, including systolic blood pressure 
less than 100 mmHg and pulse rate more than 100 
beats/min.
Post­hemorrhagic anemia was corrected with red 
blood cell transfusion (2 units, approximately 500 ml) 
at a hemoglobin threshold of 70­80 g/l.
All patients diagnosed with PUB and high­risk 
stigmata underwent initial hemostasis (injection of 
dilute epinephrine into and around the bleeding point, 
positioning of clips or thermal coagulation, or both, 
but never epinephrine alone). Two biopsy specimens 
were obtained from the gastric antrum and body in 
all patients and the presence of Helicobacter pylori 
(H. pylori) infection was assessed by histopathological 
examination of the specimens using hematoxylin­eosin 
(HE) stain.
All patients with negative histology for H. pylori 
at index endoscopy had a control endoscopy with 
repeating biopsy samples, or urea breath test (UBT), 
performed 2 wk after proton­pump inhibitor treatment 
was discontinued. Patients in whom the described 
protocol was not followed were excluded from the 
study about H. pylori infection.
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Table 1  Glasgow-Blatchford score
Assigned score
Blood urea, mmol/L 6.5 -7.9 2
8.0-9.9 3
10.0-24.9 4
≥ 25 6
Hemoglobin for men, g/dL 12 -12.9 1
10-11.9 3
< 10 6
Hemoglobin for women, g/dL 10-11.9 1
< 10 6
Systolic blood pressure, mmHg 100-109 1
90-99 2
< 90 3
Other markers Pulse ≥ 100 1
Melena 1
Syncope 2
Hepatic disease 2
Cardiac failure 2
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of variance test were used to analyze differences in 
quantitative data. The discriminative ability of the 
scoring systems to predict outcomes was evaluated by 
receiver operating characteristics curves (ROC) with 
95%CI. The areas under ROC (AUROC) curves were 
compared using the method of Delong et al[26] (1988) 
for the calculation of the standard error of the Area 
Under the Curve (AUC) and of the difference between 
two AUCs. The optimal thresholds of the GBS, RS and 
BBS for the prediction of rebleeding, death, and needs 
for blood transfusion and/or surgical intervention were 
identified as the threshold associated with the highest 
Youden index[27]. A two­tailed significance level of 
5% was used in all comparisons. All analyses were 
performed using a statistical package MedCalc for 
Windows, version 15.8 (MedCalc Software, Ostend, 
Belgium).
RESULTS
The analysis included 2643 patients with UGIB, of that 
2326 (88%) patients had non­variceal bleeding, 225 
(8.5%) had variceal bleeding, and 92 (3.5%) had an 
unidentified cause of bleeding.
From 2418 patients with non-variceal bleeding, 
41.9% (1012) had PUB; specifically, the cause of 
bleeding in 49% (496) was gastric ulcer, in 47% (476) 
duodenal ulcer, in 2.4% (24) both gastric and duodenal 
ulcer, and in 1.6% (16) gastro­enteric anastomosis 
ulcer. Endoscopic treatment was required in 58% of 
Rebleeding was defined as one or more signs 
of recurrent bleeding, including fresh hematemesis 
or melena, hematochezia, aspiration of fresh blood 
via nasogastric tube, instability of vital signs, and 
reduction of hemoglobin levels by 2 g/dl or more, 
occurring 24­h after the primary bleeding was stopped.
For all patients with gastric ulcer in whom recurrent 
bleeding was not observed, control endoscopy was 
performed 4­5 d after initial hemostasis and biopsy 
specimens were obtained from the margins and 
base of gastric ulcers to exclude malignancy. Control 
endoscopy with histology had been planned to be 
performed in all patients with gastric ulcer.
Documented clinical outcomes were: need for 
hospital­based intervention or 30­d mortality, 30­d 
rebleeding, 30­d mortality and interventions (transfer 
to the Department of Surgery and the need for blood 
transfusion).
The collected data was used to calculate the GBS 
score, as well as the pre­endoscopic RS and pre­
endoscopic BBS for each patient presenting with UGIB. 
The post­endoscopic RS and BBS were calculated 
if bleeding from gastric, duodenal or gastro­enteric 
ulcers was endoscopically diagnosed. Methods for 
calculating the GBS, RS and BBS were as previously 
described. Pre­endoscopic and post­endoscopic scores 
were separately evaluated. 
Statistical analysis
The Mann­Whitney U­test and Kruskal­Wallis analysis 
Table 2  Rockall score
Points
Variable 0 1 2 3
Pre-endoscopic score Age, yr < 60 60-79 ≥ 80
Shock Systolic blood pressure ≥ 
100
Systolic blood 
pressure ≥ 100 
mmHg
Systolic blood pressure < 100
Pulse ≥ 100/min
Pulse < 100/min
Comorbidity No major comorbidity Cardiac failure, ischemic heart 
disease, any major comorbidity
Renal failure, liver failure, 
disseminated malignancy
Post-endoscopic score Diagnosis Mallory-Weiss tear, no 
lesion identified and no 
signs of recent hemorrhage
All other diagnosis Malignancy of upper 
gastrointestinal tract
Major signs 
of recent 
hemorrhage
None or dark spot only Blood in upper gastrointestinal 
tract, adherent clot, visible or 
spurting vessel
Table 3  Baylor bleeding score
Assigned score Age, yr No. of parallel illnesses Severity of illnesses Site of bleeding Stigmata of bleeding
0 < 30 0
1 30-49 1 or 2 Clot
2 50-59
3 60-69 Visible vessel
4 3 or 4 Chronic Posterior wall bulb
5 ≥ 70 ≥ 5 Acute Active bleeding
Score Pre-endoscopic Post-endoscopic
Budimir I et al . Scoring systems for peptic ulcer bleeding
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patients with ulcer bleeding, and in 57.3% hemostasis 
was achieved with hemoclips or with combination 
hemoclips/diluted epinephrine. The rate of rebleeding 
was 9.4%, and in patients that were on anticoagulant 
therapy the rebleeding rate was 14.8% (p = 0.245), 
which was not statistically significant. In total, 5.4% 
of the patients were transferred to the Department of 
Surgery. The 30­d mortality was 5.2% and the median 
length of hospitalization was 6 d. Transfusion of red 
blood cells was performed in 49% of patients. Patients 
were predominantly men (median age 65.3). In 52% 
of patients, high-risk ulcers were verified (Forrest Ia-
Ⅱb), 11% of the patients presented with shock, and 
moderate to severe comorbidity was found in 58%. 
Furthermore, 28.1% patients with peptic ulcer had 
been taking nonsteroidal anti­inflammatory drugs, 
20% acetylsalicylic acid, 3.1% antiplatelet medication 
and 6% anticoagulant therapy. 
H. pylori testing was performed in 760 (75.1%) 
patients, of which 324 (42.6%) tested positive. Table 4 
shows the patient characteristics and clinical outcomes.
Using ROC curve analysis we found that the GBS 
was clearly superior to pre­endoscopic RS and pre­
endoscopic BBS, in predicting need for hospital­based 
intervention or 30­d mortality (AUROC 0.84 vs 0.57 vs 
0.64 respectively) (Figure 1).
The cutoff value that maximized the sum of the 
sensitivity and specificity for predicting 30-d mortality for 
the pre-endoscopic RS was 4 (sensitivity 0.63, specificity 
0.85, total 1.48), and 5 for the post­endoscopic RS 
(sensitivity 0.83, specificity 0.68, total 1.51).
Based on ROC analysis of sensitivity and specificity, 
the optimal cutoff value of the pre­endoscopic BBS for 
30-d mortality was 8 (0.63 sensitivity, 0.58 specificity, 
total 1.21), and the optimal cutoff post­endoscopic 
BBS value for 30­d mortality was 9 (0.88 sensitivity, 
0.40 specificity, total 1.28).
When assessing scores for the prediction of lethal 
outcome in patients with PUB, the pre­endoscopic 
Table 4  Patient characteristics and clinical outcomes 
Age
   Median, yr 65.3 (20-100) 
Sex
   Male/Female 638 (63)/374 (37)
Findings at endoscopy
   Gastric ulcers 496 (49)
   Duodenal ulcers 476 (47)
   Gastric and duodenal ulcers 24 (2.4)
   Ulcer on gastro-enteric anastomosis 16 (1.6)
   High-risk ulcers (Forrest Ⅰa-Ⅱb) 526 (52)
      Forrest Ⅰa 61 (6)
      Forrest Ⅰb 111 (11)
      Forrest Ⅱa 212 (21)
      Forrest Ⅱb  142 (14)
   Low- risk ulcers (Forrest Ⅱc-Ⅲ) 486 (48)
      Forrest Ⅱc 172 (17)
      Forrest Ⅲ 314 (31)
Hemodynamic shock 111 (11)
Comorbidity 
   Ischemic and valvular heart disease 213 (21.5)
   Liver disease 172 (17)
   Renal failure 111 (11)
   Any malignancy 131 (12.9)
Comorbidity (ASA class)
   ASA Ⅰ 142 (14)
   ASA Ⅱ 283 (28)
   ASA Ⅲ-Ⅳ 587 (58)
H. pylori 
   Tested 760 (75.1)
   H. pylori-positive 324 (42.6)
Drugs 
  Without previous therapy 433 (42.8)
   NSAIDs 284 (28.1)
   Acetylsalicylic acid 203 (20)
   Antiplatelet therapy 31 (3.1)
   Anticoagulant therapy 41 (4)
   NOAC 20 (2)
Treatment
   Endoscopic therapy 587 (58)
      Epinephrine 213 (36.3)
      Hemoclips 156 (26.6)
      Hemoclips + epinephrine 180 (30.7)
      Thermocoagulation 26 (4.4)
      Thermocoagulation + epinephrine 12 (2)
   Repeated endoscopic therapy 71 (7)
Blood transfusion required 496 (49)
   Red blood cell 406 (40.1)
      Median (range), unit 2.5 (1-16)
   Fresh frozen plasma 81 (8)
      Median (range), unit 2 (1-6)
   Platelet 9 (0.9)
     Median (range), unit 6 (4-8)
   Whole blood 0 (0)
Surgery 55 (5.4)
Outcome
   Rebleeding 95 (9.4)
   Rebleeding (anticoag. and NOAC) 9 (14.8)
   30-d mortality 53 (5.2)
   Median hospital stay, d 6 (0-45)
Data are presented as n (%) or mean (range). ASA: American society 
of anesthesiology; NOAC: New(er) oral anticoagulant; NSAIDs: Non-
steroidal anti-inflammatory drugs.
GBS
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Figure 1  Comparison of Glasgow-Blatchford score, pre-endoscopic 
Rockall score and pre-endoscopic Baylor bleeding score in predicting 
need for hospital-based intervention or 30-d mortality. AUROC [0.83 
(95%CI: 0.81-0.86)] vs [0.63 (95%CI: 0.59-0.68)] vs [0.57 (95%CI: 0.53-0.61)]. 
GBS: Glasgow-Blatchford score; BBS: Baylor bleeding score; RS: Rockall 
score.
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RS was superior compared to the GBS and the pre­
endoscopic BBS (AUROC 0.82 vs 0.67 vs 0.63, 
respectively) (Figure 2A). 
Based on the ROC analysis of sensitivity and 
specificity, the optimal cutoff GBS value for 30­d 
mortality was 12 (0.49 sensitivity, 0.75 specificity, 
total 1.24), for rebleeding 11 (0.71 sensitivity, 0.67 
specificity, total 1.38), for blood transfusion 9 (0.71 
sensitivity, 0.67 specificity, total 1.38) and for surgery 
12 (0.71 sensitivity, 0.76 specificity, total 1.47).
The GBS score was superior to the pre­endoscopic 
RS and BBS in the prediction of rebleeding (AUROC 0.75 
vs 0.61 vs 0.52) (Figure 2B). 
The GBS score was superior to the pre­endoscopic 
RS and BBS in predicting the need for blood trans­
fusion (AUROC 0.83 vs 0.63 vs 0.59, respectively) 
(Figure 2C) and transfer to the Department of Surgery 
(AUROC 0.82 vs 0.63 vs 0.52, respectively) (Figure 
2D). Also, the post­endoscopic RS was superior to the 
post­endoscopic BBS (AUROC 0.82 vs 0.69) in the 
prediction of lethal outcome (Figure 3A). 
There was no significant difference between the 
post­endoscopic RS and BBS in the prediction of 
rebleeding (AUROC 0.70 vs 0.73) (Figure 3B). 
The rebleeding cutoff point that maximized the sum 
of the sensitivity and specificity for the pre-endoscopic 
BBS was 3 (sensitivity 0.90, specificity 0.19, total 1.09), 
and 11 for the post­endoscopic BBS (sensitivity 0.66, 
specificity 0.76, total 1.42).
There was no significant difference between the 
post­endoscopic RS and BBS in predicting the need for 
blood transfusion (AUROC 0.68 vs 0.71) (Figure 3C) 
and transfer to the Department of Surgery (AUROC 
0.68 vs 0.74) (Figure 3D).
DISCUSSION
UGIB is the most important cause of emergency 
gastroenterological admissions and the most frequent 
condition requiring emergency endoscopy[1]. The most 
common causes of acute UGIB are non­variceal, of 
which 30% to 60% are attributed to PUB[28]. In our 
study, 42% of all non­variceal bleeding was caused 
by PUB. In order to assess the adequate timing of 
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Figure 2  Comparison of the Glasgow-Blatchford score, pre-endoscopic Rockall score and pre-endoscopic Baylor bleeding score for the prediction of 
death, recurrent bleeding, transfusion or surgical intervention. A: AUROC [0.67 (95%CI: 0.64-0.70)] vs [0.82 (95%CI: 0.79-0.84)] vs [0.63 (95%CI: 0.60-0.66)]; B: 
AUROC [0.75 (95%CI: 0.72-0.78)] vs [0.61 (95%CI: 0.57-0.64)] vs [0.52 (95%CI: 0.49- 0.56)]; C: AUROC [0.83 (95%CI: 0.80-0.85)] vs [0.63 (95%CI: 0.59-0.66)] vs [0.58 
(95%CI: 0.55-0.62)]; D: AUROC [0.82 (95%CI: 0.79-0.84)] vs [0.63 (95%CI: 0.60-0.66)] vs [0.52 (95%CI: 0.48-0.55)]. GBS: Glasgow-Blatchford score; BBS: Baylor 
bleeding score; RS: Rockall score.
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endoscopy and selection of patients for hospital 
admission, several scoring systems for risk estimation 
have been developed. With the array of available 
scoring systems, it is often difficult to select the ideal 
scoring system for a particular patient or clinical 
outcome of interest. Therefore, in this study, we 
compared the performance of these scoring systems in 
the risk assessment of various clinical outcomes. 
Our study showed that the GBS is superior to the 
pre­endoscopic RS and BBS in predicting need for 
hospital­based intervention or 30­d mortality. This 
is in concordance with the results from a study by 
laursen[22] and a study by Bryant et al[19]. Our study 
also showed that the GBS is superior to the pre­
endoscopic RS and BBS in predicting peptic ulcer 
re­bleeding. An explanation for why the GBS best 
predicts peptic ulcer rebleeding is that it incorporates 
hemoglobin and serum urea values. Serum urea is 
a good biochemical marker for UGIB because it rises 
rapidly when there is catabolism of isoleucine­poor 
hemoglobin[8,29]. The maximal level of hemoglobin and 
urea account for half of the maximal sum of points in 
the GBS score.
Our study showed that there is no significant 
difference between the post­endoscopic BBS and post­
endoscopic RS in predicting peptic ulcer rebleeding. 
This is in concordance with the results from a study by 
laursen et al[6]. Similar data was published by Italian 
and Dutch researchers, who also found low values 
under the ROC curve [(0.59­0.68) and 0.61] and 
concluded that the RS is not appropriate for prediction 
of rebleeding[16,30]. 
Our study showed that the GBS is superior to 
the pre­endoscopic RS and pre­endoscopic BBS in 
predicting the needs for blood transfusion and/or 
transfer to the Department of Surgery. The ROC curve 
for GBS rebleeding was similar to the GBS ROC curve 
for blood transfusion requirement and transfer to the 
Department of Surgery because peptic ulcer rebleeding 
is the main cause of blood transfusion requirement and 
need for surgical intervention. Bryant et al[19] published 
similar data.
Our study showed that the pre­endoscopic RS 
was superior to the GBS and pre­endoscopic BBS 
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Figure 3  Comparison of the post-endoscopic Rockall score and post-endoscopic Baylor bleeding score for the prediction of death recurrent bleeding, 
transfusion or surgical intervention. AUROC: [0.82 (95%CI: 0.79-0.84)] vs [0.69 (95%CI: 0.65-0.72)]; B: AUROC [0.70 (95%CI: 0.67-0.73)] vs [0.73 (95%CI: 
0.70-0.76)]; C: AUROC [0.66 (95%CI: 0.62-0.70)] vs [0.65 (95%CI: 0.61-0.69)]; D: AUROC [0.68 (95%CI: 0.65-0.71)] vs [0.74 (95%CI: 0.71-0.77)]. BBS: Baylor 
bleeding score; RS: Rockall score.
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in predicting mortality. The RS best predicted fatal 
outcome because it incorporated the majority of risk 
factors (age, shock, moderate to severe co­morbidities 
and high­risk endoscopic signs for rebleeding), which 
was valuable in a multivariate analysis of risk for fatal 
outcome[7,13,30,31]. Our study showed that the post­
endoscopic RS is superior to the post­endoscopic 
BBS in predicting lethal outcome in patients with 
PUB. laursen[22] did not find any significant difference 
in AUROC among post­endoscopic BBS and post­
endoscopic RS. 
According to studies by Hyett et al[14] and Bryant 
et al[19], the GBS cutoff points for high­risk of lethal 
outcome and rebleeding were ≥ 10 and ≥ 12, 
respectively. In a recent retrospective study, lim 
et al[32] suggested urgent endoscopy in the first 13 
h after clinical presentation in high­risk patients with 
GBS > 12, in the first 24 h in patients with GBS > 7 
and for patients with GBS values between 4 and 7 
urgent endoscopy in the first 24 h is recommended, 
but not necessary.
Our cutoff points for high­risk of rebleeding and 
lethal outcome in PUB patients are significantly 
different in comparison with original research papers 
(GBS ≥ 2, pre­endoscopic BBS > 5, post­endoscopic 
BBS ≥ 10, post­endoscopic RS ≥ 4), which all refer to 
UGIB[6­9,13,14]. An explanation for this could be that the 
original series included an unselected group of patients 
with UGIB, with a significant proportion of patients 
with a low­risk of death, recurrent bleeding, and needs 
for blood transfusion and/or surgical intervention. 
These were patients that presented with low­risk 
bleeding ulcers (Forrest Ⅱc and Forrest Ⅲ), Mallory­
Weiss syndrome, ulcerative esophagitis, angiodysplasia 
and portal hypertensive gastropathy. 
When considering possible limitations of our study, 
there is always a certain level of subjectivity in the 
endoscopic classification of ulcers and variation in 
endoscopic treatment. Furthermore, our study had a 
relatively short follow­up period of 30 d. 
By comparing the ROC curves of the aforemen­
tioned pre­endoscopic scores, the RS proved to be 
the best score for predicting lethal outcome. The 
post­endoscopic RS was also better than the post­
endoscopic BBS in predicting lethal outcome in pati­
ents with PUB. On the other hand, among the three 
pre­endoscopic scores, the GBS best predicted need 
for hospital­based intervention or 30­d mortality, 
rebleeding, and needs for blood transfusion and/or 
surgical intervention.
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